協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/11/30 | 1,672 | 1,673 | 1,625 | 1,632 | -37 | -2.2% | 1,691,600 |
| 2016/11/29 | 1,681 | 1,683 | 1,657 | 1,669 | -8 | -0.5% | 1,472,900 |
| 2016/11/28 | 1,688 | 1,695 | 1,665 | 1,677 | -11 | -0.7% | 813,400 |
| 2016/11/25 | 1,685 | 1,697 | 1,677 | 1,688 | +12 | +0.7% | 959,900 |
| 2016/11/24 | 1,707 | 1,707 | 1,676 | 1,676 | -40 | -2.3% | 1,113,200 |
| 2016/11/22 | 1,690 | 1,722 | 1,687 | 1,716 | +17 | +1% | 1,279,900 |
| 2016/11/21 | 1,700 | 1,713 | 1,692 | 1,699 | +35 | +2.1% | 1,228,600 |
| 2016/11/18 | 1,691 | 1,694 | 1,658 | 1,664 | -18 | -1.1% | 1,492,100 |
| 2016/11/17 | 1,675 | 1,693 | 1,664 | 1,682 | +4 | +0.2% | 1,013,300 |
| 2016/11/16 | 1,658 | 1,685 | 1,647 | 1,678 | +27 | +1.6% | 1,576,500 |
| 2016/11/15 | 1,678 | 1,678 | 1,641 | 1,651 | -27 | -1.6% | 1,660,900 |
| 2016/11/14 | 1,700 | 1,720 | 1,663 | 1,678 | -13 | -0.8% | 1,658,600 |
| 2016/11/11 | 1,706 | 1,714 | 1,654 | 1,691 | +105 | +6.6% | 3,739,500 |
| 2016/11/10 | 1,545 | 1,591 | 1,517 | 1,586 | +155 | +10.8% | 2,223,300 |
| 2016/11/09 | 1,514 | 1,533 | 1,424 | 1,431 | -70 | -4.7% | 2,079,000 |
| 2016/11/08 | 1,510 | 1,567 | 1,489 | 1,501 | -6 | -0.4% | 1,040,000 |
| 2016/11/07 | 1,519 | 1,524 | 1,500 | 1,507 | +2 | +0.1% | 1,241,300 |
| 2016/11/04 | 1,530 | 1,535 | 1,490 | 1,505 | -36 | -2.3% | 1,127,400 |
| 2016/11/02 | 1,581 | 1,581 | 1,530 | 1,541 | -51 | -3.2% | 1,028,200 |
| 2016/11/01 | 1,598 | 1,607 | 1,587 | 1,592 | -13 | -0.8% | 793,300 |
| 2016/10/31 | 1,600 | 1,623 | 1,576 | 1,605 | -36 | -2.2% | 1,261,900 |
| 2016/10/28 | 1,645 | 1,658 | 1,628 | 1,641 | +15 | +0.9% | 1,013,500 |
| 2016/10/27 | 1,609 | 1,626 | 1,607 | 1,626 | +10 | +0.6% | 699,100 |
| 2016/10/26 | 1,616 | 1,630 | 1,608 | 1,616 | -6 | -0.4% | 782,900 |
| 2016/10/25 | 1,628 | 1,638 | 1,614 | 1,622 | +1 | +0.1% | 809,200 |
| 2016/10/24 | 1,600 | 1,622 | 1,591 | 1,621 | +33 | +2.1% | 988,900 |
| 2016/10/21 | 1,612 | 1,613 | 1,583 | 1,588 | -12 | -0.8% | 683,900 |
| 2016/10/20 | 1,580 | 1,600 | 1,576 | 1,600 | +22 | +1.4% | 1,101,600 |
| 2016/10/19 | 1,583 | 1,594 | 1,569 | 1,578 | -1 | -0.1% | 759,700 |
| 2016/10/18 | 1,540 | 1,584 | 1,538 | 1,579 | +40 | +2.6% | 1,021,700 |
| 2016/10/17 | 1,529 | 1,549 | 1,518 | 1,539 | +5 | +0.3% | 879,600 |
| 2016/10/14 | 1,570 | 1,571 | 1,534 | 1,534 | -46 | -2.9% | 1,338,400 |
| 2016/10/13 | 1,582 | 1,586 | 1,568 | 1,580 | +2 | +0.1% | 605,600 |
| 2016/10/12 | 1,558 | 1,588 | 1,557 | 1,578 | -4 | -0.3% | 750,300 |
| 2016/10/11 | 1,568 | 1,584 | 1,568 | 1,582 | +16 | +1% | 707,200 |
| 2016/10/07 | 1,553 | 1,569 | 1,550 | 1,566 | ±0 | ±0% | 739,700 |
| 2016/10/06 | 1,580 | 1,580 | 1,551 | 1,566 | -8 | -0.5% | 816,100 |
| 2016/10/05 | 1,598 | 1,600 | 1,571 | 1,574 | -17 | -1.1% | 632,900 |
| 2016/10/04 | 1,597 | 1,598 | 1,576 | 1,591 | ±0 | ±0% | 792,700 |
| 2016/10/03 | 1,600 | 1,611 | 1,587 | 1,591 | +5 | +0.3% | 645,900 |
| 2016/09/30 | 1,579 | 1,592 | 1,553 | 1,586 | -13 | -0.8% | 1,041,200 |
| 2016/09/29 | 1,601 | 1,611 | 1,591 | 1,599 | +7 | +0.4% | 602,500 |
| 2016/09/28 | 1,603 | 1,612 | 1,580 | 1,592 | -30 | -1.8% | 588,600 |
| 2016/09/27 | 1,586 | 1,622 | 1,565 | 1,622 | +27 | +1.7% | 1,062,400 |
| 2016/09/26 | 1,613 | 1,620 | 1,589 | 1,595 | -35 | -2.1% | 898,900 |
| 2016/09/23 | 1,630 | 1,638 | 1,611 | 1,630 | +12 | +0.7% | 898,900 |
| 2016/09/21 | 1,590 | 1,619 | 1,553 | 1,618 | +41 | +2.6% | 1,253,000 |
| 2016/09/20 | 1,550 | 1,581 | 1,550 | 1,577 | -8 | -0.5% | 984,300 |
| 2016/09/16 | 1,564 | 1,587 | 1,557 | 1,585 | +37 | +2.4% | 869,200 |
| 2016/09/15 | 1,580 | 1,580 | 1,536 | 1,548 | -50 | -3.1% | 1,412,900 |
2101～
2150
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 251,300円 | -3.5% | -11.3% | 2.39% | 23.08倍 | 1.55倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 140,200円 | +0.9% | +380.2% | 5.56% | 19.31倍 | 1.66倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 250,600円 | +20.9% | +10.6% | 2.63% | 11.85倍 | 1.57倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 413,000円 | +0.1% | -3.4% | 3.87% | 28.08倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 158,400円 | +0.6% | +43.3% | 5.05% | 11.11倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
